記事 | サターラ

記事

Article X

When Will There Be a COVID-19 Vaccine for Kids?

記事

So You Have COVID Antibodies—Do You Still Need to Get Vaccinated? Here’s What Doctors Say

記事

Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States

記事

Australia’s current COVID-19 treatment options, and why the national fatality rate is so high

記事

Modelling and simulation facilitates drug repurposing to counter Covid-19

記事

Legislators: Bring all stakeholders to the table to lower drug costs

記事

EMPLOYING REAL-WORLD EVIDENCE TO IMPROVE CLINICAL TRIAL STRATEGIES

記事

Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence

記事

Can Biosimulation Provide the Key to Unlocking the Neurodegenerative Disease Development Challenge?

記事

Certara Reports Preliminary Fourth Quarter and Full Year 2020 Results and Issues Full Year 2021 Guidance

記事

Scientific Computing World: Connecting Science

記事

View more resources

注目製品

D360 科学的インフォマティクスプラットフォーム

特集

GlobalSubmit ウェブレビューの 30 日間無料トライアル

人気製品・コンテンツ

Simcyp：20 イノベーションの軌跡

100 PBPK モデリングシミュレーションの理解に役立つ記事

Biohaven achieves FDA approval with Nurtec™

最新ニュース

Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies

Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance

注目製品

D360 科学的インフォマティクスプラットフォーム

特集

GlobalSubmit ウェブレビューの 30 日間無料トライアル

人気製品・コンテンツ

Simcyp：20 イノベーションの軌跡

100 PBPK モデリングシミュレーションの理解に役立つ記事

Biohaven achieves FDA approval with Nurtec™

最新ニュース

Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies

Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance

記事

記事

When Will There Be a COVID-19 Vaccine for Kids?

So You Have COVID Antibodies—Do You Still Need to Get Vaccinated? Here’s What Doctors Say

How COVID-19 has fundamentally changed clinical research in global health

Covid-19 Vaccine: How Private-Equity Portfolio Companies Played a Role

Scientists work toward an elusive dream: a simple pill to treat Covid-19

Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States

Australia’s current COVID-19 treatment options, and why the national fatality rate is so high

Modelling and simulation facilitates drug repurposing to counter Covid-19

Legislators: Bring all stakeholders to the table to lower drug costs

EMPLOYING REAL-WORLD EVIDENCE TO IMPROVE CLINICAL TRIAL STRATEGIES

Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence

Can Biosimulation Provide the Key to Unlocking the Neurodegenerative Disease Development Challenge?

Certara Reports Preliminary Fourth Quarter and Full Year 2020 Results and Issues Full Year 2021 Guidance

Scientific Computing World: Connecting Science

Simcyp：20 イノベーションの軌跡

100 PBPK モデリングシミュレーションの理解に役立つ記事

Biohaven achieves FDA approval with Nurtec™

Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies

Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance

Simcyp：20 イノベーションの軌跡

100 PBPK モデリングシミュレーションの理解に役立つ記事

Biohaven achieves FDA approval with Nurtec™

Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies

Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance

記事

記事

When Will There Be a COVID-19 Vaccine for Kids?

So You Have COVID Antibodies—Do You Still Need to Get Vaccinated? Here’s What Doctors Say

How COVID-19 has fundamentally changed clinical research in global health

Covid-19 Vaccine: How Private-Equity Portfolio Companies Played a Role

Scientists work toward an elusive dream: a simple pill to treat Covid-19

Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States

Australia’s current COVID-19 treatment options, and why the national fatality rate is so high

Modelling and simulation facilitates drug repurposing to counter Covid-19

Legislators: Bring all stakeholders to the table to lower drug costs

EMPLOYING REAL-WORLD EVIDENCE TO IMPROVE CLINICAL TRIAL STRATEGIES

Get the latest from Certara

Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence

Can Biosimulation Provide the Key to Unlocking the Neurodegenerative Disease Development Challenge?

Certara Reports Preliminary Fourth Quarter and Full Year 2020 Results and Issues Full Year 2021 Guidance

Scientific Computing World: Connecting Science